Biohaven Ltd. (BHVN): A Bull Case Theory [Yahoo! Finance]
Biohaven Pharmaceutical Holding Company Ltd. Common Shares (BHVN)
Last biohaven pharmaceutical holding company ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on BHVN. Biohaven Ltd.'s share was trading at $11.54 as of February 18th. 25 Best Work-Life Balance Jobs to Enjoy Life Photographee.eu/Shutterstock.com Biohaven Ltd. is a clinical-stage biotechnology company targeting large global markets with significant unmet needs across neurology, immunology, and oncology, with lead programs such as its Kv7 activator franchise representing potential blockbuster opportunities that could justify a multi-fold increase from its roughly $1.4 billion market capitalization if even one or two Phase 3 trials succeed. The company's long-term vision is to evolve into a multi-franchise, platform-driven biopharma powered by proprietary technologies, including MoDE protein degraders and ion-channel modulators, where a single late-stage success could validate the broader platform and create a durable innovation engine. Its competitive advantage stems from proven execution, highlighted by the developmen
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Pharmaceutical Holding Company Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Biohaven (BHVN) had its price target lowered by HC Wainwright from $11.00 to $10.00. They now have a "neutral" rating on the stock.MarketBeat
- Biohaven (BHVN) had its "outperform" rating reaffirmed by Leerink Partners.MarketBeat
- Biohaven (BHVN) had its price target raised by Royal Bank Of Canada from $22.00 to $23.00. They now have an "outperform" rating on the stock.MarketBeat
- Biohaven Non-GAAP EPS of -$0.90 beats by $0.06 [Seeking Alpha]Seeking Alpha
- Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
BHVN
Earnings
- 3/2/26 - Beat
BHVN
Sec Filings
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- BHVN's page on the SEC website